EN HU

Kovács Árpád

Kovács Árpád

Publication list

Uploaded publications:
35
Publications in DEA:
35
OA:
25
Date range:
2014-2024
2024
1.
Kovács, Á., Zhazykbayeva, S., Herwig, M., Fülöp, G. Á., Csípő, T., Oláh, N., Hassoun, R., Budde, H., Osman, H., Kaçmaz, M., Jaquet, K., Priksz, D., Juhász, B., Akin, I., Papp, Z., Schmidt, W., Mügge, A., El-Battrawy, I., Tóth, A., Hamdani, N.: Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.
GeroScience. 46 (5), 4543-4561, 2024.
Journal metrics:
Q1 Aging (2023)
Q1 Cardiology and Cardiovascular Medicine (2023)
D1 Complementary and Alternative Medicine (2023)
Q1 Geriatrics and Gerontology (2023)
D1 Veterinary (miscellaneous) (2023)
2023
2.
Kovács, Á.: Az új jelszó a csökkent ejekciós frakcióval járó szívelégtelenség bázisterápiájában: ASAP!.
Cardiol. Hung. 53 (5), 502-506, 2023.
3.
Zhazykbayeva, S., Hassoun, R., Herwig, M., Budde, H., Kovács, Á., Mannherz, H. G., El-Battrawy, I., Tóth, A., Schmidt, W., Mügge, A., Hamdani, N.: Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats.
Front. Cardiovasc. Med. 10, 1-14, (article identifier: 1157398), 2023.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine
4.
Kovács, Á., Barta, J.: Renin-Angiotensin-Aldosterone System as an Old New Target in Heart Failure Therapy: RAAS Inhibition in Heart Failure.
In: The Renin Angiotensin System in Cardiovascular Disease. Eds.: Naranjan S. Dhalla, Sukhwinder K. Bhullar, Anureet K. Shah, Springer, New York, 307-330, 2023, (Advances in Biochemistry in Health and Disease, ISSN 2512-2142 ; 24)
2022
5.
Gömöri, K., Herwig, M., Hassoun, R., Budde, H., Mostafi, N., Delalat, S., Modi, S., Begovic, M., Szabados, T., Pipis, J., Farkas-Morvay, N., Leprán, I., Kovács, Á., Mügge, A., Ferdinándy, P., Görbe, A., Bencsik, P., Hamdani, N.: Altered Cellular Protein Quality Control System Modulates Cardiomyocyte Function in Volume Overload-Induced Hypertrophy.
Antioxidants. 11 (11), 1-16, 2022.
Journal metrics:
Q1 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
D1 Food Science
Q2 Molecular Biology
Q1 Physiology
6.
Gömöri, K., Herwig, M., Budde, H., Hassoun, R., Mostafi, N., Zhazykbayeva, S., Sieme, M., Modi, S., Szabados, T., Pipis, J., Farkas-Morvay, N., Leprán, I., Ágoston, G., Baczkó, I., Kovács, Á., Mügge, A., Ferdinándy, P., Görbe, A., Bencsik, P., Hamdani, N.: Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.
ESC Heart Failure. 9 (4), 2585-2600, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
7.
Budde, H., Hassoun, R., Mügge, A., Kovács, Á., Hamdani, N.: Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction.
Front. Physiol. 13, 1-18, 2022.
Journal metrics:
Q2 Physiology
Q1 Physiology (medical)
8.
Hassoun, R., Budde, H., Zhazykbayeva, S., Herwig, M., Sieme, M., Delalat, S., Mostafi, N., Gömöri, K., Tangos, M., Jarkas, M., Pabel, S., Bruckmüller, S., Skrygan, M., Lódi, M., Jaquet, K., Sequeira, V., Gambichler, T., Remedios, C., Kovács, Á., Mannherz, H. G., Mügge, A., Sossalla, S., Hamdani, N.: Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Int. J. Cardiol. 347, 44-45, 2022.
9.
Priksz, D., Lampé, N., Kovács, Á., Herwig, M., Bombicz, M., Varga, B., Wilisicz, T., Szilvássy, J., Pósa, A., Kiss, R., Gesztelyi, R., Ráduly, A. P., Szekeres, R., Sieme, M., Papp, Z., Tóth, A., Hamdani, N., Szilvássy, Z., Juhász, B.: Nicotinic-acid derivative BGP-15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy.
Br. J. Pharmacol. 179 (10), 2240-2258, 2022.
Journal metrics:
D1 Pharmacology
10.
Tangos, M., Budde, H., Kolijn, D., Sieme, M., Zhazykbayeva, S., Lódi, M., Herwig, M., Gömöri, K., Hassoun, R., Robinson, E. L., Meister, T. L., Jaquet, K., Kovács, Á., Mustroph, J., Evert, K., Babel, N., Fagyas, M., Lindner, D., Püschel, K., Westermann, D., Mannherz, H. G., Paneni, F., Pfaender, S., Tóth, A., Mügge, A., Sossalla, S., Hamdani, N.: SARS-CoV-2 infects human cardiac myocytes promoted by inflammation and oxidative stress.
Int. J. Cardiol. 362, 196-205, 2022.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
2021
11.
Fagyas, M., Bánhegyi, V., Úri, K., Enyedi, A., Lizanecz, E., Mányiné Siket, I., Mártha, L., Fülöp, G. Á., Radovits, T., Pólos, M., Merkely, B., Kovács, Á., Szilvássy, Z., Ungvári, Z., Édes, I., Csanádi, Z., Boczán, J., Takács, I., Szabó, G., Balla, J., Balla, G., Seferović, P. M., Papp, Z., Tóth, A.: Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
GeroScience. 43 (5), 2289-2304, 2021.
Journal metrics:
D1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
D1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
12.
Kolijn, D., Pabel, S., Tian, Y., Lódi, M., Herwig, M., Carrizzo, A., Zhazykbayeva, S., Kovács, Á., Fülöp, G. Á., Falcao-Pires, I., Reusch, P. H., Linthout, S. V., Papp, Z., Heerebeek, L. v., Vecchione, C., Maier, L. S., Ciccarelli, M., Tschöpe, C., Mügge, A., Bagi, Z., Sossalla, S., Hamdani, N.: Empagliflozin Improves Endothelial and Cardiomyocyte Function in Human Heart Failure With Preserved Ejection Fraction via Reduced Pro-Inflammatory-Oxidative Pathways and Protein Kinase Gα Oxidation.
Cardiovasc. Res. 117 (2), 495-507, 2021.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
D1 Physiology
D1 Physiology (medical)
13.
Pappritz, K., Dong, F., Miteva, K., Kovács, Á., El-Shafeey, M., Kerim, B., O'Flynn, L., Elliman, S. J., O'Brien, T., Hamdani, N., Tschöpe, C., Linthout, S. V.: Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.
Front. Cardiovasc. Med. 8, 1-13, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
14.
Kovács, Á., Herwig, M., Budde, H., Delalat, S., Kolijn, D., Bódi, B., Hassoun, R., Tangos, M., Zhazykbayeva, S., Balogh, Á., Czuriga, D., Linthout, S. V., Tschöpe, C., Dhalla, N. S., Mügge, A., Tóth, A., Papp, Z., Barta, J., Hamdani, N.: Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.
Antioxidants. 10 (6), 1-21, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
15.
Bódi, B., Kovács, Á., Gulyás, H., Mártha, L., Tóth, A., Mátyás, C., Barta, B. A., Oláh, A., Merkely, B., Radovits, T., Papp, Z.: Long-Term PDE-5A Inhibition Improves Myofilament Function in Left and Right Ventricular Cardiomyocytes through Partially Different Mechanisms in Diabetic Rat Hearts.
Antioxidants. 10 (11), 1-13, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
16.
Pappritz, K., Klein, O., Dong, F., Hamdani, N., Kovács, Á., O'Flynn, L., Elliman, S., O'Brien, T., Tschöpe, C., Linthout, S. V.: MALDI-IMS as a Tool to Determine the Myocardial Response to Syndecan-2-Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy.
Proteom. Clin. Appl. 15 (1), 1-10, 2021.
Journal metrics:
Q2 Clinical Biochemistry
17.
Fülöp, G. Á., Oláh, A., Csípő, T., Kovács, Á., Pórszász, R., Veress, R., Horváth, B., Nagy, L., Bódi, B., Fagyas, M., Helgadottir, S. L., Bánhegyi, V., Juhász, B., Bombicz, M., Priksz, D., Nánási, P. P. i., Merkely, B., Édes, I., Csanádi, Z., Papp, Z., Radovits, T., Tóth, A.: Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans.
Basic Res. Cardiol. 116 (1), 24, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
Q1 Physiology
Q1 Physiology (medical)
18.
Hassoun, R., Budde, H., Zhazykbayeva, S., Herwig, M., Sieme, M., Delalat, S., Mostafi, N., Gömöri, K., Tangos, M., Jarkas, M., Pabel, S., Bruckmüller, S., Skrygan, M., Lódi, M., Jaquet, K., Sequeira, V., Gambichler, T., Remedios, C., Kovács, Á., Mannherz, H. G., Mügge, A., Sossalla, S., Hamdani, N.: Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy.
Int. J. Cardiol. 344, 160-169, 2021.
Journal metrics:
Q1 Cardiology and Cardiovascular Medicine
19.
Budde, H., Hassoun, R., Tangos, M., Zhazykbayeva, S., Herwig, M., Varatnitskaya, M., Sieme, M., Delalat, S., Sultana, I., Kolijn, D., Gömöri, K., Jarkas, M., Lódi, M., Jaquet, K., Kovács, Á., Mannherz, H. G., Sequeira, V., Mügge, A., Leichert, L. I., Sossalla, S., Hamdani, N.: The Interplay between S-Glutathionylation and Phosphorylation of Cardiac Troponin I and Myosin Binding Protein C in End-Stage Human Failing Hearts.
Antioxidants. 10 (7), 1-26, 2021.
Journal metrics:
Q2 Biochemistry
Q2 Cell Biology
Q1 Clinical Biochemistry
Q2 Molecular Biology
Q2 Physiology
2020
20.
Reil, J. C., Reil, G. H., Kovács, Á., Sequeira, V., Waddingham, M. T., Lódi, M., Herwig, M., Ghaderi, S., Kreusser, M. M., Papp, Z., Voigt, N., Dobrev, D., Meyhöfer, S., Langer, H. F., Maier, L. S., Linz, D., Mügge, A., Hohl, M., Steendijk, P., Hamdani, N.: CaMKII Activity Contributes to Homeometric Autoregulation of the Heart: a Novel Mechanism for the Anrep Effect.
J. Physiol.-London. 598 (15), 3129-3153, 2020.
Journal metrics:
Q1 Physiology
D1 Sports Science
21.
Kolijn, D., Kovács, Á., Herwig, M., Lódi, M., Sieme, M., Alhaj, A., Sandner, P., Papp, Z., Reusch, P. H., Haldenwang, P., Falcao-Pires, I., Linke, W. A., Jaquet, K., Linthout, S. V., Mügge, A., Tschöpe, C., Hamdani, N.: Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
Front. Physiol. 11, 1-21, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
22.
Herwig, M., Kolijn, D., Lódi, M., Hölper, S., Kovács, Á., Papp, Z., Jaquet, K., Haldenwang, P., Dos Remedios, C., Reusch, P. H., Mügge, A., Krüger, M., Fielitz, J., Linke, W. A., Hamdani, N.: Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D.
Front. Physiol. 11, 240, 2020.
Journal metrics:
Q2 Physiology
Q2 Physiology (medical)
23.
Lódi, M., Bánhegyi, V., Bódi, B., Gyöngyösi, A., Kovács, Á., Árokszállási, A., Hamdani, N., Fagyas, M., Édes, I., Csanádi, Z., Czuriga, I., Kisvárday, Z., Lekli, I., Bai, P., Tóth, A., Papp, Z., Czuriga, D.: Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 18 (1), 470, 2020.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2019
24.
Lódi, M., Priksz, D., Fülöp, G. Á., Bódi, B., Gyöngyösi, A., Nagy, L., Kovács, Á., Kertész, A. B., Kocsis, J., Édes, I., Csanádi, Z., Czuriga, I., Kisvárday, Z., Juhász, B., Lekli, I., Bai, P., Tóth, A., Papp, Z., Czuriga, D.: Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
J. Transl. Med. 17, 229, 2019.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
2018
25.
Pabel, S., Wagner, S., Bollenberg, H., Bengel, P., Kovács, Á., Schach, C., Tirilomis, P., Mustroph, J., Renner, A., Gummert, J., Fischer, T., Linthout, S. V., Tschöpe, C., Streckfuss-Bömeke, K., Hasenfuß, G., Maier, L. S., Hamdani, N., Sossalla, S.: Empagliflozin directly improves diastolic function in human heart failure.
Eur. J. Heart Fail. 20 (12), 1690-1700, 2018.
Journal metrics:
D1 Cardiology and Cardiovascular Medicine
DEENK University of Debrecen
© 2012 University of Debrecen